These findings are consistent with recent studies, where ESR1 was reported to suppress liver carcinogenesis [31], while ESR2 gene polymorphisms (e.g., rs2978381) were shown to significantly increase the risk of HBV-related liver cirrhosis and HCC [32]. This evidence concerns the gene ESR2 and cirrhosis of liver.